Health at the Cellular Level: A Focus on Equine Health
Equine GP is a revolutionary bio-available food that effectively operates at a primary cellular level.

The direct cellular impact of Equine GP reaches far beyond targeting symptoms, it also provides a natural systemic action that supports the repair and renewal of cellular function and mitochondrial ATP.

Humans and animals alike depend on an abundant production and regeneration of ATP molecules, which support the constant cellular energy demands required to sustain both normal activity and optimum health.

Perfect for Healthy Horses
Breeders and trainers are enthusiastically reporting remarkable results, after feeding Equine GP to animals suffering due to compromised health.

The benefits of disease prevention and health maintenance are important. The benefits of disease prevention and health maintenance for performance animals are invaluable.

As a direct absorption supplement, Equine GP provides essential nutrients (glycoprotein’s) that are not available in routine feeding programs.

Equine GP is the perfect addition to daily nutrition for healthy and high performance horses.

Increased Cellular Function
Veterinarians have discovered that most disease and degeneration in the body can often be directly related to cellular malfunction. Therefore any supplement enhancing cellular functionality predictably improves the overall health and performance of your animal.

Equine GP has shown significant positive results in:

• Semen
  quality increase up to 30%
• Ovulation Periods
  more consistent cycles; shortened periods of transition
• Tendon Strength
  significant improvement; fewer injuries; shorter down times
• Training / Competition
  reduced fatigue; increased stamina

Research
Preliminary research performed at the University of Wisconsin - Stevens Point has shown that the glycoproteins in Equine GP has the ability to increase Cellular ATP as quantified through ATP Dependent Oxidation of Luciferin by Luciferase. Continued research may also suggest an improvement in the ADP to ATP kinetics.

Forest Bonack
Lead Research Coordinator